-
A
Framework for Integrating Resource Management into
Strategic R&D Decision Making
-
Interactive
Panel: Centralized vs. Decentralized Management of
Resources: Which System and Philosophy Works Best?
-
Identify
the People Resources You Need to bring a Candidate
from Development to Market
-
Metrics
Used to Determine if a Company is Managing Resources
more Effectively
-
Approaches
to Estimate Demand and Define Capacity for a Portfolio
of Projects
|
|
Pre-Conference
Tutorial - Thursday, September 18, 2003
Case Studies on
How Pharmaceutical Companies are Implementing Resource Management
Programs
Presented
by Deloitte Consulting
|
| Lead
Sponsoring Publication: |
Sponsoring
Publication: |
 |
|
| Web
Partner: |
|
|
|
|
|
|
|
Forum Participants
Include:
|
Marisa
Co, Director, Development Finance, Amgen
Sally McLeish, Vice President, Global,Development Operations
Management, Amgen
Alister Thomson,Director, Strategy and Resource Optimization, Bristol-Myers
Squibb
Chet Andruskiewicz, Director of Resource Planning, Centocor
Sue Steven, MBA, Ph.D.,Executive Director, Portfolio Planning and
Resource Management, Centocor
Jan Malek,Leader, Pharma/Biotech R&D Practice, Deloitte
Consulting
Paul Bunch,Manager, Capacity Planning & Management, Project
Management, Eli Lilly
Beverley Mangham, Director R&D Manpower Forecasting &
Analysis, GlaxoSmithKline |
Peter
Benton,Vice President, Central Planning, Johnson & Johnson
Pharmaceutical R&D, L.L.C.
Suzanne Brown,Senior Director, Resource Management, J&J PRD, Johnson
& Johnson Pharmaceutical R&D, L.L.C.
Haim Albalak,President, Marketbee Technologies Inc.
Gus Cicala,President & CEO, Project Assistants, Inc.
Jeff Hewitt, Principal,Strategic Decisions Group
Dennis Engers,Director, International Preclinical Planning,
Sanofi-Synthelabo
Richard J. Heaslip, Ph.D.,Vice President, Project Planning &
Administration, Project Management, Wyeth Research
Jann Nielsen, Ph.D.,Director, Project Management, Wyeth
Research |
|
Day One, September 18
|
|
Pre-Conference Tutorial
8:00-11:30 Case Studies: How Pharmaceutical Companies
are Implementing Resource Management Programs
This workshop will explore what it takes to reach a
state where resource management is an effective and highly value-added
component of the R&D portfolio management process. Specifically, we
will focus on the issues that the implementation leaders of such efforts
will need to address and how they can do so effectively. If you are
embarking on a new initiative, this workshop will provide you with a
preview of what is ahead and will help you avoid repeating the mistakes of
those who went before you.
Specific issues that we will address in this workshop
include:
• Laying the groundwork for success
• Selecting the technology that is right
for your organization
• Getting constructive input from the
organization
• Determining scope - how much can you
handle in the first iteration?
• The triangle of successful
implementations: people, process, technology
• Identifying the most likely points of
resistance and figuring out how to deal with them, in advance
• Getting credit for your great
achievement!
• Q&A
About the workshop leader:
Jan Malek is the leader of
Deloitte Consulting's Pharma/Biotech R&D practice in Boston. In his
consulting practice, Jan assists leading life science companies with
R&D Portfolio-Project-Resource Management initiatives, among others.
He is a frequent contributor to industry publications and his articles
include Running a Tight Ship, PE, Feb. 2002, which deals with
R&D resource management. He is also a frequent speaker at industry
meetings.
|
|
|
Main Conference
12:00 Main Conference Registration
1:00 Chairperson's Opening Remarks
Gus Cicala, President & CEO, Project Assistants,
Inc.
 |
1:15 Why is Resource Management
so Important to the Future of the Pharmaceutical Industry? |
|
This topic will discuss a number of the external
elements that are putting pressure on the pharmaceutical industry to do
better resource planning. These include the productivity of R&D, the
reimbursement environment, the consolidation of the industry, and the
increased number of partnerships between companies.
Sue Steven, MBA, Ph.D., Executive Director, Portfolio
Planning and Resource Management, Centocor
|
2:00 A Framework for Integrating Resource Management
into Strategic R&D Decision Making
• Identify the key business decisions and processes
that are impacted by strategic resource management (resource additions,
reallocations, portfolio prioritization)
• Develop and implement decision frameworks and models
to drive the decision processes
• Identify and resolve resource bottlenecks across the
entire R&D organization
Paul Bunch, Manager, Capacity Planning & Management,
Project Management, Eli Lilly
2:45 An Integrated Approach to Resource Management
• Top-down allocation to support company strategy
• Bottom-up planning for achieving realistic
objectives
• Efficiency tracking capability for real-time
feedback
• Leveraging past experiences for future planning
Haim Albalak, President, Marketbee Technologies Inc.
3:30 Networking Refreshment Break
3:50 Maximizing Pipeline Investments Using Enterprise
Project Management
• Collapse product development lifecycles
• Streamline enterprise resource management
• Increase speed to market
• Make better decisions
Gus Cicala
4:30 Centralized vs. Decentralized Management of
Resources: Which System and Philosophy Work Best?
Moderator: Jeff Hewitt,
Principal, Strategic Decisions Group
Panelists: Suzanne Brown,
Senior Director, Resource Management, J&J PRD
Dennis Engers, Director, International Preclinical
Planning, Sanofi-Synthelabo
Beverley Mangham, Director R&D Manpower Forecasting
& Analysis, GlaxoSmithKline
5:30 Close of Day One
Day Two, September 19
7:45 Coffee
8:15 Chairperson's Remarks
Gus Cicala
 |
8:25 A Case Study - Creation of
a New Global Development Operations Capacity Management Function
|
|
Ten dimensions of capacity and resource management
capabilities used to:
• Assess current practices
• Conduct benchmarking within and outside pharma
• Design the desired future state
• Process design for workload demand and supply-demand
balancing at three levels of detail and over three distinct time horizons
• Develop scenarios for testing conceptual process
design
• Report requirements and prototypes for three
constituent groups
• Conduct systems assessment and gap analysis, and
determine high-level functional requirements
• Incorporate challenges and lessons from change
implementation
Sally McLeish, Vice President of Global Development
Process and Capacity Management, Amgen
Marisa Co, Director of Development Finance, Amgen
|
9:05 Structuring Resources across Teams and Functions to
Meet Corporate Goals
In a complex and dynamic environment, teams compete for
the same valuable resources and expect top priority from each functional
unit. To maximize success, it is critical to develop a standard and
validated approach to estimate project demand and its impact on functional
capacity. Once the impact of project goals on the functional capacity is
understood, better supported portfolio recommendations can be made to meet
corporate goals. A case study will be shared on the progress of meeting
the demands of the teams and functions at J&J PRD.
Suzanne Brown
9:50 Networking Refreshment Break
10:10 Communication: The Key to Successful Strategic
Resource Management
• Do you have a successful resource strategy if it is
not developed with good communication from the bottom up and top down?
• Project plans are the foundation of portfolio
management. How good is the communication involved in the development of
your plans?
• Is your portfolio management transparent, i.e. well
communicated?
• Are your strategy, resource allocation and
decision-making aligned from a communication standpoint?
• This is the information age - will your company be
communicating well in 2010?
Jann Nielsen, Ph.D., Director, Project Management, Wyeth
Research
10:55 Identify the People Resources You Need to Bring
a Candidate from Development to Market
How Do Companies Ensure They
Have Resources to Support Their Portfolios?''
• Estimating resource needs in the short term and long
term
• Measuring the extent of the capacity you have
available
• Measuring and acting upon the impact of change
management: time, revised strategy, new projects, temporal and strategic
attrition, etc.
• Measuring performance/productivity - actual vs.
forecast, best practices
Beverley Mangham
11:40 Resource Capacity Analysis: Understanding
Internal Skill Sets and Evaluating External Resources
• The process of monitoring the type of projects in
the pipeline
• How large a portfolio can we support?
• Measuring and monitoring capacity across different
departments
• Understanding resource constraints and integrating
that information into the decision-making process
Alister Thomson, Director, Strategy and Resource
Optimization, Bristol-Myers Squibb
| 12:25 Luncheon
Technology Workshop |
Sponsored by |
|
Presented
by Keith Vadas, Pro Model Solutions
|

|
|
|
|
|
 |
1:45 Project Planning and
Resource Management: Strategic Foundations for "World Class
Business Planning"
|
• Drug development: business or a science?
• Complexity of drug development: unpredictable?
• Drug development: can it be planned?
• Questions: do I ask the right ones and do I have any
answers?
• So, what should I focus on first?
Peter Benton, Vice President, Central Planning. Johnson
& Johnson Pharmaceutical R&D, L.L.C.
|
 |
2:30 Resource Optimization -
Increasing the Overall Value of your Portfolio
|
• Using knowledge of resources to adjust the portfolio
to the right number of projects
• Building a flexible resource pool
• Understanding financial objectives and constraints
• Determining the best resource distribution to
maximize pipeline growth
• Using metrics to determine whether a company is
managing resources effectively
Richard J. Heaslip, Ph.D., Vice President, Project Planning &
Administration, Project Management, Wyeth Research
|
3:15 Resource Distribution across Research and
Development
• What resources need to be managed and by whom?
• Understanding functional department demand and
capacity
• How to redistribute FTE allocations when making
strategic adjustments to projects
• Acquiring functional buy-in to resource management
process and numbers
• Development of the process to build the partnership
between project management, resource management, functional management and
finance
Chet Andruskiewicz, Director of Resource Planning,
Centocor
4:00 Close of Executive Forum
 |
Promotion-Free
Roundtrip Ticket! |
|
• All paid registrants attending either the a)
Conference & Tutorial, or b) Conference Only will receive one (1) US
Airways Take Flight Certificate, good for one free roundtrip airline
ticket anywhere in the continental United States and Canada where US
Airways flies.
• Tickets are valid on code share flights, including
code share flights operated by United Airlines.
• Take Flight Certificates have NO blackout dates.
• Take Flight Certificate holders earn US Airways
Dividend miles on their flights.
• Take Flight Certificate is good for 12 months after
the conference dates.
• Take Flight Certificate will be either handed to you
upon arrival at conference or mailed to you via United States Postal
Service within six weeks of conference close.
• Tutorial Only registrants are NOT eligible.
• Registration has to be paid in full by July 24, 2003 to be eligible.
• For complete US Airways Terms and Conditions, please
visit www.healthtech.com/terms.asp or call Eric Glazer at
781-972-5442 for additional information.
Please Note: Take Flight Certificates will not be
issued prior to the conference.
|
|
|
Who Should Attend?
Strategic Resource Management is being produced for Vice
Presidents, Heads of Departments, Directors and Managers in the following
areas:
|
• Resource Management
• Project Planning
• R&D Finance
• Strategic Planning
• Project Management
• Marketing Finance
• Corporate Strategy
• Clinical Development
• Process Management
• Portfolio Management
• Technology
• Global Strategic Marketing
• Business Strategy
• Licensing
• Market Research
• Decision Analysis
• Business Development
• Operations
• Finance
• Informatics |
|
|
|
Call for Sponsors and Exhibitors |
|
CHI offers a variety of conference sponsorships designed to bring your
company face to face with key executive decision-makers, position your
solutions/services and increase revenue opportunities in a highly
competitive marketplace. You will interact with Vice Presidents, Heads of
Departments and Directors of Biotechnology and Biopharmaceutical
companies, who will attend this focused executive forum.
For details, please contact:
Arnie Wolfson at 617- 630-1331; email: awolfson@healthtech.com
|
Hotel Information
Hyatt Regency Philadelphia at
Penn's Landing
201 South Columbus Blvd., Philadelphia, PA 19106
T: 215-928-1234 F: 215-521-6600
Room Rate: $139.00/S $159/D
Cut-off Date: September 4, 2003
Please call the hotel directly
to make your room reservation. Identify yourself as a Cambridge Healthtech
Institute conference attendee to receive the reduced room rate.
Reservations made after the cut-off date or after the group room block has
been filled (whichever comes first) will be accepted on a
space-and-rate-availability basis. Rooms are limited, so please book
early.
www.pharmaseries.com
|